Two Sigma Securities’s InMed Pharmaceuticals INM Stock Holding History

Two Sigma Securities’s Portfolio INM Stock Details INM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17K	Sell	10,945 -7,773	-42%	-$8.59K	﹤0.01%	1507
2026 Q1	$12.1K	Buy	+18,718	New	+$17.6K	﹤0.01%	1447
2024 Q2	–	Sell	-771	Closed	-$5.61K	–	3314
2024 Q1	$5.61K	Buy	771 +126	+20%	+$926	﹤0.01%	2826
2023 Q4	$5.36K	Buy	+645	New	+$6.26K	﹤0.01%	2876
2022 Q2	–	Sell	-36	Closed	-$17K	–	2520
2022 Q1	$17K	Buy	+36	New	+$18.9K	﹤0.01%	1996

Other funds holding INM

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

UFM

Ursa Fund Management Danville, California $1.28B AUM 89.08% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Two Sigma Securities's INM Position: Q2 2026 in Review

Two Sigma Securities reduced its InMed Pharmaceuticals (INM) stake by 42% in Q2 2026, selling an estimated $8.59K and leaving 10,945 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1507.

Two Sigma Securities first reported a position in INM in Q1 2022 and has held it in 5 quarters since. The position peaked at $17K in Q1 2022. 20 funds tracked by Wall St. Rank hold INM as of Q2 2026.

Two Sigma Securities held 10,945 shares of InMed Pharmaceuticals worth $17K as of Q2 2026.
Two Sigma Securities sold 7,773 InMed Pharmaceuticals shares in Q2 2026, an estimated $8.59K.
InMed Pharmaceuticals made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1507 holding.
Two Sigma Securities first reported a position in InMed Pharmaceuticals in Q1 2022 and has held it in 5 quarters since.
Two Sigma Securities's InMed Pharmaceuticals position peaked at $17K in Q1 2022.
20 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.